Marine Bio (MBII) Reports Q4 Loss of Per Share $0.45

Marine Bio (NASDAQ: MBII) reported Q4 EPS of ($0.45), versus ($0.66) reported last year. Revenue for the quarter came in at $1.9 million, versus $1.1 million reported last year.

For earnings history and earnings-related data on Marine Bio (MBII) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• Genco rejects Diana Shipping takeover bid as undervalued